These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 11176281)
1. Transforming growth factor-beta1 in the cerebrospinal fluid of patients with subarachnoid hemorrhage: titers derived from exogenous and endogenous sources. Flood C; Akinwunmi J; Lagord C; Daniel M; Berry M; Jackowski A; Logan A J Cereb Blood Flow Metab; 2001 Feb; 21(2):157-62. PubMed ID: 11176281 [TBL] [Abstract][Full Text] [Related]
2. TGF beta1 and TGF beta2 and their role in posthemorrhagic hydrocephalus following SAH and IVH. Kaestner S; Dimitriou I J Neurol Surg A Cent Eur Neurosurg; 2013 Sep; 74(5):279-84. PubMed ID: 23690072 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor and transforming growth factor-beta1 are highly expressed in the cerebrospinal fluid of premature infants with posthemorrhagic hydrocephalus. Heep A; Stoffel-Wagner B; Bartmann P; Benseler S; Schaller C; Groneck P; Obladen M; Felderhoff-Mueser U Pediatr Res; 2004 Nov; 56(5):768-74. PubMed ID: 15319463 [TBL] [Abstract][Full Text] [Related]
4. Inflammatory cytokine cascade released by leukocytes in cerebrospinal fluid after subarachnoid hemorrhage. Takizawa T; Tada T; Kitazawa K; Tanaka Y; Hongo K; Kameko M; Uemura KI Neurol Res; 2001 Oct; 23(7):724-30. PubMed ID: 11680512 [TBL] [Abstract][Full Text] [Related]
5. High CSF transforming growth factor beta levels after subarachnoid haemorrhage: association with chronic communicating hydrocephalus. Douglas MR; Daniel M; Lagord C; Akinwunmi J; Jackowski A; Cooper C; Berry M; Logan A J Neurol Neurosurg Psychiatry; 2009 May; 80(5):545-50. PubMed ID: 19066194 [TBL] [Abstract][Full Text] [Related]
6. Accumulation of transforming growth factor-beta2 and nitrated chondroitin sulfate proteoglycans in cerebrospinal fluid correlates with poor neurologic outcome in preterm hydrocephalus. Chow LC; Soliman A; Zandian M; Danielpour M; Krueger RC Biol Neonate; 2005; 88(1):1-11. PubMed ID: 15711035 [TBL] [Abstract][Full Text] [Related]
7. [Association of chronic hydrocephalus after aneurysmal subarachnoid hemorrhage with transforming growth factor-β1 levels and other risk factors]. Liu F; Yuan W; Liao D; Zhang T; Wang Z Nan Fang Yi Ke Da Xue Xue Bao; 2013 Mar; 33(3):382-5. PubMed ID: 23529236 [TBL] [Abstract][Full Text] [Related]
8. Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease. Zetterberg H; Andreasen N; Blennow K Neurosci Lett; 2004 Sep; 367(2):194-6. PubMed ID: 15331151 [TBL] [Abstract][Full Text] [Related]
9. Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis. Sakaguchi K; Kitano M; Nishimura M; Senoh T; Ohta T; Terao M; Shinji N; Koide N; Tsuji T Hepatogastroenterology; 2004; 51(60):1780-3. PubMed ID: 15532825 [TBL] [Abstract][Full Text] [Related]
11. Elevation of transforming growth factor-beta 1 level in cerebrospinal fluid of patients with communicating hydrocephalus after subarachnoid hemorrhage. Kitazawa K; Tada T Stroke; 1994 Jul; 25(7):1400-4. PubMed ID: 8023355 [TBL] [Abstract][Full Text] [Related]
12. Growth factor modulation of CSF formation by isolated choroid plexus: FGF-2 vs. TGF-beta1. Hakvoort A; Johanson CE Eur J Pediatr Surg; 2000 Dec; 10 Suppl 1():44-6. PubMed ID: 11214837 [No Abstract] [Full Text] [Related]
13. Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients. Rota E; Bellone G; Rocca P; Bergamasco B; Emanuelli G; Ferrero P Neurol Sci; 2006 Apr; 27(1):33-9. PubMed ID: 16688597 [TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of nasal polyposis by immunoglobulin E and interleukin-5 is completed by transforming growth factor-beta1. Hirschberg A; Jókúti A; Darvas Z; Almay K; Répássy G; Falus A Laryngoscope; 2003 Jan; 113(1):120-4. PubMed ID: 12514394 [TBL] [Abstract][Full Text] [Related]
15. Comparison of cerebrospinal fluid biomarkers between idiopathic normal pressure hydrocephalus and subarachnoid hemorrhage-induced chronic hydrocephalus: a pilot study. Lee JH; Park DH; Back DB; Lee JY; Lee CI; Park KJ; Kang SH; Cho TH; Chung YG Med Sci Monit; 2012 Dec; 18(12):PR19-25. PubMed ID: 23197244 [TBL] [Abstract][Full Text] [Related]
16. Decorin alleviated chronic hydrocephalus via inhibiting TGF-β1/Smad/CTGF pathway after subarachnoid hemorrhage in rats. Yan H; Chen Y; Li L; Jiang J; Wu G; Zuo Y; Zhang JH; Feng H; Yan X; Liu F Brain Res; 2016 Jan; 1630():241-53. PubMed ID: 26556770 [TBL] [Abstract][Full Text] [Related]
17. Overproduction of transforming growth factor-beta1 (TGF-beta1) is associated with adhesion formation and peritoneal fibrinolytic impairment. Holmdahl L; Kotseos K; Bergström M; Falk P; Ivarsson ML; Chegini N Surgery; 2001 May; 129(5):626-32. PubMed ID: 11331455 [TBL] [Abstract][Full Text] [Related]
18. Serum levels of transforming growth factor beta1 are significantly correlated with venous invasion in patients with gastric cancer. Lin Y; Kikuchi S; Obata Y; Yagyu K; J Gastroenterol Hepatol; 2006 Feb; 21(2):432-7. PubMed ID: 16509870 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity. Fujiwara M; Muragaki Y; Ooshima A Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401 [TBL] [Abstract][Full Text] [Related]
20. Serum and tissue expression of transforming growth factor beta 1 in psoriasis. Zaher H; Shaker OG; EL-Komy MH; El-Tawdi A; Fawzi M; Kadry D J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):406-9. PubMed ID: 19175705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]